Nursing role for pediatric patients with Anti – NMDA receptor encephalitis
Keywords:
nursing role, pediatric patients, Anti–NMDA receptor encephalitisAbstract
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is caused by disorder of autoimmune system which resists to NMDA receptor. It resulted in neurological and psychiatric symptoms. Although, the disease incidence is rare in children, but the symptoms of disease are complex and difficult to diagnose. If diagnosis and treatment are delayed, it will result in long term abnormalities or even cause of death. The treatment for this disease includes for acute phase, while having signs and symptoms; and long term phase, for rehabilitation and treatment of residual disorders. In addition, the children need continuing care to prevent disease relapsing. Therefore, health care team have to understand the disease’s causes, sypmtoms, and treatment guidelines; in order to prepare for caring of pediatric patients in each stage of treatment. This article presents nursing role in caring for pediatric patients with anti – NMDA receptor encephalitis according to professional standards of nursing practice which are compose of five main issues, including nursing practice using a nursing process, patient advocacy, professional ethics, quality improvement of nursing practice, and continuing care management as well as nursing report and documentation. These nursing roles are important parts for nurses to assess symptoms and provide effective comprehensive nursing care and improve health problems of patients, which will contribute to help patients to be safe and reduce complications that may occur from treatment.
References
Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic Anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25–36.
Dalmau J, Bataller L. Limbic encephalitis: The new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications. Neurologia 2007;22(8):526-37.
Titular MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Lizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with Anti-NMDA receptor encephalitis: An observational cohort study. Lancet Neurol 2013; 12(2):157–65. doi:10.10 16/S1474-4422(12)70310-1.
Weerawan S. Anti-NMDA receptor encephalitis. Epilepsy Digest 2011; 3-5. (in Thai)
Sai Y, Zhang X, Feng M, Tang J, Liao H, Tan L, et al. Clinical diagnosis and treatment of pediatric anti-N-methyl-D-aspartate receptor encephalitis: a single center retrospective study. Exp Ther Med 2018; 16(2):1442-8. doi:10.3892/etm.2018.6329.
Apiwattanakul M. Autoimmune encephalitis. Thai Journal of Neurology 2014; 30(1):1-8. (in Thai)
Remy KE, Custer JW, Cappell J, Foster CB, Garber NA, Walker LK, et al. Pediatric Anti-N-Methyl-d-Aspartate receptor encephalitis: A review with pooled analysis and critical care emphasis. Front Pediatr. 2017 Nov 24; 5:250. doi:10.3389/fped.2017.00250.
Thepwiwatjit S, Jitprapaikulsan J. Anti-NMDA-receptor encephalitis of Thai patients: Description of a consecutive series of patients over 10 Years and a literature review. Journal of the Medical Association of Thailand 2018; 101:163-71. (in Thai)
Thailand Nursing and Midwifery Council. Anual report 2019. Nonthaburi: Suetawan Publishing; 2020.
Bhat P, Ahmed A, Jolepalem P, Sittambalam C. A case report: Anti-NMDA receptor encephalitis. J Community Hosp Intern Med Perspect 2018; 8(3):158-60. doi:10.1080/ 20009666.2018.1481326.
Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune n-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis 2012; 54(7):899–904. doi:10.1093/cid/cir1038.
Kasemsap N, Kongbunkiat K, Tiamkao S. Interesting case: Behavioral change in young women. North-Eastern Thai Journal of Neuroscience 2013;8(2):93-101. (in Thai)
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with Anti-NMDAR encephalitis. Lancet Neurol 2011;10(1):63-74. doi:10.1016/S1474-4422(10)70253-2.
Prüss H, Finke C, Höltje M, Hofmann J, Klingbeil C, Probst C, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012; 72(6):902-11. doi: 10.1002/ana.23689.
Food and drug administration. Rational drug use handbook to special access medicine of national list of essential medicine (E II). Bangkok: The Agricultural Cooperative Federation of Thailand; 2010. (in Thai)
Barry H, Byrne S, Barrett E, Murphy KC, Cotter DR. Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull 2015;39(1):19-23. doi:10.1192/pb.bp.113.045518.
Kuewong G. The COVID-19: Nursing practice for pediatric patients. Journal of Nursing Sciences & Health 2020;43(4):1-11. (in Thai)
Downloads
Published
How to Cite
Issue
Section
License
The Journal of Nursing Science and Health is copyright holder of published articles. Distributions of articles published in Journal of Nursing Science and Health including online, photocopying which is not for teaching-learning purpose, publication submission elsewhere are prohibited except obtaining permission from the Journal of Nursing Science and Health.
